Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
专家展望：nurix therapeutics的14位分析师观点
In the last three months, 14 analysts have published ratings on Nurix Therapeutics (NASDAQ:NRIX), offering a diverse range of perspectives from bullish to bearish.
在过去三个月中，共有14位分析师对Nurix Therapeutics（NASDAQ：NRIX）进行了评级，在看好和看淡等各种角度上提供了不同的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Nurix Therapeutics, presenting an average target of $28.5, a high estimate of $35.00, and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 4.28% from the previous average price target of $27.33.
在对12个月价格目标的评估中，分析师揭示了Nurix Therapeutics的见解，呈现出28.5美元的平均目标，35.00美元的高估值和20.00美元的低估值。当前平均价格目标已比之前的平均价格目标27.33美元上涨了4.28%。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The standing of Nurix...
通过对最...
登录免费看全文
登录/注册